| With the near ubiquity of interconnected smartphones and computers in modern life, it can be difficult to remember just how quickly our familiarity with data has evolved. Data, in digital form, seem to be everywhere we look. Yet, we are still at an early stage in our ability to apply data to understand and treat disease and address other public health challenges. At this early stage, even small advances in our ability to gain useful insights from data can represent significant opportunities. In September 2019, when we announced the U.S. Food and Drug Administration's Technology Modernization Action Plan (TMAP) we spoke about the ways that the FDA is modernizing our approach to the use of technology for the agency's regulatory mission, such as in the review of medical product applications and food safety, and other critical functions. Data modernization is the next step in the agency's overhaul of its approach to technology and data, and we are pleased today to announce the Data Modernization Action Plan (DMAP). | | | |
No comments:
Post a Comment